Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aplindore in Early Stage Parkinson's Disease
NCT00623324Phase 2Completed
- Sponsor
- Ligand Pharmaceuticals
- Start
- Jan 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aplindore in Parkinson's disease (PD), sponsored by Ligand Pharmaceuticals. Started Jan 2008; status: completed.
02
Drugs
aplindore
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00623324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623324.